Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.44    -0.005 (-0.20%)
Bid:
2.43
Ask:
2.445
Spread: 0.015 (0.617%)
Market Cap: $8.05b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

Final Results

11 Feb 2009 07:00

RNS Number : 1196N
Commercial Intnl Bank (Egypt) SAE
10 February 2009
 



Commercial International Bank (Egypt) S.A.E.

Financial Statements

December 31, 2008

COMMERCIAL INTERNATIONAL BANK (EGYPT) S.A.E

FINANCIAL POSITION 

 

 

 

 

As of December 31, 2008

Amounts in L.E.

Note

Dec. 31, 2008

Dec. 31, 2007

restated

Assets

Cash & Due From Central Bank

4

6,493,358,437

4,953,205,430

Due From Banks

5

4,391,051,249

13,782,062,043

Treasury Bills & Other Notes Discountable at CBE

6

12,449,007,406

2,948,674,319

Trading Financial Investments

7

497,554,487

588,473,270

Loans & Overdrafts

10&11

26,330,327,878

20,478,590,841

Financial Derivatives

12

704,890,792

75,307,833

Financial Investments

Available for Sale

8

2,762,232,983

2,347,587,666

Held to Maturity 

8

681,263,274

443,894,166

Financial Investments in Subsidiary and associated companies

13

1,138,332,672

365,723,936

Debit Balances and Other Assets

15

942,621,482

1,020,565,573

Deferred Tax

21,840,568

52,819,475

Fixed Assets (Net)

16

715,251,587

607,104,820

Total Assets

57,127,732,815

47,664,009,372

Liabilities & Shareholders' Equity

Liabilities

Due to Banks

17

213,470,012

2,377,082,435

Customer Deposits

18

48,938,109,663

39,514,539,992

Financial Derivatives

12

636,914,744

63,166,763

Dividends & Profit Sharing

-

336,727,470

Credit Balances & Other Liabilities

19

1,194,593,545

735,103,795

Long Term Loans

20

109,273,933

161,356,219

Other Provisions

21

363,218,186

395,332,813

Total Liabilities

51,455,580,083

43,583,309,487

Shareholders' Equity

Issued & Paid- in Capital

22

2,925,000,000

1,950,000,000

Reserves

22

1,033,696,029

2,089,911,959

Reserve for employee stock ownership plan (ESOP) 

30

86,727,903

29,159,584

Retained Earning

11,628,342

11,628,342

Total Shareholders' Equity

4,057,052,274

4,080,699,885

Net Profit of the Year

1,615,100,458

0

Total Shareholders' Equity & Net Profit

5,672,152,732

4,080,699,885

Total Liabilities & Shareholders' Equity 

57,127,732,815

47,664,009,372

Contingent & commitments Liabilities

23

13,290,994,705

11,559,866,680

COMMERCIAL INTERNATIONAL BANK (EGYPT) S.A.E

INCOME STATEMENT

For Year Ended December 31, 2008

Amounts in LE.

Note

Dec. 31, 2008

Dec. 31, 2007

Restated

Interest and similar income

24

3,772,875,880

2,993,373,614

Interest and similar expenses

24

(1,963,661,240)

(1,796,702,031)

Net Interest Income

1,809,214,640

1,196,671,583

Fees and Commissions income

686,456,733

547,669,248

Fees and Commissions Expense

(73,587,145)

(25,286,540)

Net Income from Fees and Commissions

612,869,588

522,382,708

Dividends Income

141,572,634

66,158,925

Net Trading Income

25

337,579,386

276,191,855

Provisions

11&21

(394,545,539)

(250,416,667)

Profit (losses) from Financial Investments

8

115,831,055

226,135,001

Administrative Expenses

(949,681,007)

(636,363,618)

Other Operating Income

9

183,048,413

181,676

Net Profit before Tax

1,855,889,170

1,400,941,463

Income Tax

28

(209,809,805)

(180,303,950)

Deferred Tax

27

(30,978,907)

12,186,756

Net Profit After Tax

1,615,100,458

1,232,824,269

Earning per share

Basic

29

4.89

3.73

Diluted

29

4.84

3.71

COMMERCIAL INTERNATIONAL BANK (EGYPT) S.A.E

CASH FLOW STATEMENT 1a

For Year Ended Dec. 31, 2008

Amounts in LE.

Dec. 31, 2008

Dec. 31, 2007

Restated

Cash Flow From Operating Activities

Net Income Before Tax

1,855,889,170

1,400,941,463

Adjustments To Reconcile Net Income

Total Net Cash Provided by operating

Depreciation

153,818,325

120,918,839

Provisions (Additions during the period)

394,545,539

250,416,667

Trading Financial Investment Evaluation Diff.

87,784,923

(7,680,871)

Impairment of Assets

54,837,345

(4,185,378)

Utilization of Provision (Other than Provision for Doubtful Debts)

(10,943,385)

-

Provisions No Longer Used

(165,365,215)

(7,036,600)

Difference in revaluation of FCY Provision Balances

(Except Doubtful Debts)

516,745

(1,904,981)

Gains From Selling of Fixed Assets

(5,052,568)

(1,269,870)

Profit From Selling of Investments

(219,181,953)

(174,061,817)

Profits from Dispose part of a Subsidiary

(50,258,991)

(148,393,558)

FCY Revaluation Difference of Long Term Loans

(922,993)

1,733,674

Share based payments

57,568,319

29,159,584

Operating Profit Before Changes in Operating Assets and Liabilities

2,153,235,261

1,458,637,152

Net Decrease (Increase) in Assets

Due from banks

9,567,610,757

(7,960,703,701)

Treasury Bills & Other Governmental Notes 

(7,353,852,038)

2,266,818,190

Trading Financial Assets

3,133,860

306,349,739

Financial Derivatives (Net) 

80,117,118

(12,141,070)

Loans & Overdrafts

(6,220,116,065)

(3,054,288,046)

Debit Balances & Other Assets

(13,465,835)

(199,356,212)

Net Increase (Decrease) In Liabilities

Due to Banks

(2,163,612,423)

1,164,558,315

Customer Deposits

9,423,569,671

7,914,312,674

Credit Balances & Other Liabilities

237,857,404

(150,080,573)

Income Tax paid

(29,422,851)

(80,317,367)

Net Cash Provided from Operating Activities

5,685,054,859

1,653,789,221

COMMERCIAL INTERNATIONAL BANK (EGYPT) S.A.E

CASH FLOW STATEMENT 1b

For Year Ended Dec.31,2008

Dec. 31, 2008

Dec. 31, 2007

Restated

Cash Flow From Investment Activities

Sale (Purchase) of Subsidiaries & Associated Companies

(772,608,736)

107,524,396

Prepaid for Fixed Assets, premises and Fitting-out of Branches

(142,698,585)

(278,980,037)

Redemption of Held-to-Maturity Investments

276,189,303

-

Held to Maturity Financial Investment Purchases

(513,558,411)

378,390,172

Available for Sale Financial Investments

(281,257,648)

1,121,812,258

Net Cash (Used in) Investment Activities

(1,433,934,077)

1,328,746,789

Cash Flow From Financing Activities

Increase (Decrease) in Long Term Loans

(51,159,293)

60,455,684

Dividends Paid

(336,727,470)

(287,235,147)

Net Cash (Used in) provided from Financing Activities

(387,886,763)

(226,779,463)

Net cash & cash equivalent Changes

3,863,234,019

2,755,756,547

Beginning Balance of cash and cash equivalent

6,779,152,548

4,023,396,001

Cash & Cash equivalent Balance At the End of the Year

10,642,386,576

6,779,152,548

Cash & Cash Equivalent are Represented as Follows

Cash and Due from Central Bank

6,493,358,437

4,953,205,430

Due From Banks

4,391,051,249

13,782,062,043

Treasury Bills & Other Governmental Notes

12,449,007,406

2,948,674,319

Due From Banks (Time Deposits)

(3,696,607,777)

(13,264,218,534)

Treasury Bills with Maturity More than Three Months

(8,994,422,748)

(1,640,570,710)

Total Cash & Cash Equivalent

10,642,386,567

6,779,152,548

COMMERCIAL INTERNATIONAL BANK (EGYPT) S.A.E

STATEMENT OF CHANGES IN SHAREHOLDERS EQUITY

As of December 31, 2008

2007

Capital

Legal Reserves

General Reserves

Retained Earning*

Special Reserves

Reserves for Inv. Rev.*

Profits of the year

Reserve for ESOP

Total

Beginning Balance

1,950,000,000

371,230,872

548,482,934

-

162,709,903

7,458,634

-

-

3,039,882,343

Effect of Adjusting Accounting Standards

-

-

 -

61,784,246

332,016

80,445,723

-

-

142,561,985

Beginning Balance After Adjustments

1,950,000,000

371,230,872

548,482,934

61,784,246

163,041,919

87,904,357

-

-

3,182,444,328

Effect of Adjusting Accounting Standard

-

-

-

(50,155,904)

50,567,396

-

(411,492)

-

-

Transfer to Reserves

-

61,620,639

834,064,668

-

-

-

(895,685,307)

-

-

Dividends Paid

-

-

-

-

-

-

(336,727,470)

-

(336,727,470)

Usage Part of Reserve

-

-

-

-

-

(27,000,826)

-

-

(27,000,826)

Adjusted Net Profits of the Year

-

-

-

-

-

-

1,232,824,269

-

1,232,824,269

Reserve for Employee Stock Ownership plan (ESOP)**

-

-

-

-

-

-

-

29,159,584

29,159,584

Ending Balance

1,950,000,000

432,851,511

1,382,547,602

11,628,342

213,609,315

60,903,531

0

29,159,584

4,080,699,885

2008

Capital

Legal Reserves

General Reserves

Retained Earning*

Special Reserves

Reserves for Inv. Rev.

Profits of the year

Reserve for ESOP

Total

Beginning Balance

1,950,000,000

432,851,511

1,382,547,602

11,628,342

213,609,315

60,903,531

0

29,159,584

4,080,699,885

Retained Earning

-

Net Profits of the Period

-

-

-

-

-

1,615,100,458

-

1,615,100,458

Capital Increase*

975,000,000

-

(975,000,000)

-

-

-

-

-

Usage Part of Reserve

-

-

-

-

(81,215,930)

-

-

(81,215,930)

Reserve for ESOP

-

-

-

-

-

-

57,568,319

57,568,319

Ending Balance

2,925,000,000

432,851,511

407,547,602

11,628,342

213,609,315

(20,312,399)

1,615,100,458

86,727,903

5,672,152,732

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR CKKKPKBKBKBD
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.